Researcher
Daan De Maeseneer
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Education curriculum, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Basic and Applied Medical Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Pharmacology (Department)
Member
From1 Oct 2017 → 30 Sep 2018
Publications
1 - 10 of 23
- Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial(2023)
Authors: Mathieu Spaas, Nora Sundahl, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Fréderic Duprez, Yolande Lievens, Veerle Surmont, Lieve Brochez, Dries Reynders, et al.
Pages: 1205 - 1213 - Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial(2022)
Authors: P. Dirix, C. Berghen, M. Albersen, S. Junius, N. Liefhooghe, L. Noé, G. De Meerleer, Piet Ost, Daan De Maeseneer, Flor Verghote, et al.
Pages: 1238 - 1245 - Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial(2021)Volume: 161
Authors: Mathieu Spaas, Nora Sundahl, VIBEKE KRUSE, Daan De Maeseneer, Piet Dirix, Robin Van den Begin, Dirk Van Gestel, Vincent Renard, D Reynders, Els Goetghebeur, et al.
Pages: S490 - S491 - Retrospective analysis of mpMRI to predict complete pathologic response after neo-adjuvant chemotherapy for muscle invasive bladder cancer(2021)Volume: 39
Authors: Daan De Maeseneer, Pieter De Visschere, Mats Van den broecke, Geert Villeirs, Karel Decaestecker, Sylvie Rottey
Number of pages: 1 - Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial(2021)
Authors: Flor Verghote, Lindsay Poppe, Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost, Pieter De Visschere, Kathia De Man, Daan De Maeseneer
- Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial(2021)
Authors: Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Daan De Maeseneer, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, et al.
- Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium(2018)
Authors: Piet Ost, Bart De Troyer, Gert De Meerleer, Daan De Maeseneer, Dirk De Ridder
Pages: e1159 - e1169 - Checkpoint inhibition : new treatment options in urologic cancer(2017)
Authors: Daan De Maeseneer, Brant Delafontaine
Pages: 24 - 28 - Parathyroid adenoma mimicking a malignant lymph node on F-18-choline PET-CT(2017)
Authors: Bliede Van den Broeck, Daan De Maeseneer, Ruth De Gersem, Kathia De Man
Pages: E207 - E209 - Multicenter cross-sectional study comparing quality of life, body image after breast cancer surgery(2013)Volume: 22
Authors: Daan De Maeseneer, MICHIEL STRIJBOS, Phillip Blondeel, Rudy Van den Broecke, Herman Depypere, Geert Braems, Hannelore Denys, Simon Van Belle, Veronique Cocquyt
Pages: S76 - S76